ASP Isotopes Inc.
Close on Oct 19, 2026
- Market cap
- $252.18M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 4, 2026 | Before market open | – | – | – |
Press releases
Announcements ASP Isotopes filed with the SEC
Quantum Leap Energy and Necsa Sign Binding Heads of Agreement to Establish Joint Venture for HALEU Production in South Africa
Regulation FD disclosure · EX-99.1 to Form 8-K
ASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational Update
Regulation FD disclosure · EX-99.1 to Form 8-K
ASP Isotopes Inc. Announces that Renergen Limited’s Subsidiary has Commenced Commissioning of Liquid Helium Plant in South Africa
Regulation FD disclosure · EX-99.1 to Form 8-K
ASP Isotopes Announces Quantum Leap Energy is Evaluating Metal Conversion Opportunities in Namibia
Regulation FD disclosure · EX-99.1 to Form 8-K
ASP Isotopes to Participate in Citi’s 2026 Natural Resources Conference
Regulation FD disclosure · EX-99.1 to Form 8-K
ASP Isotopes Issues Letter to Shareholders
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
ASP Isotopes to Participate in Canaccord Genuity’s 46th Annual Growth Conference on August 12, 2026
Regulation FD disclosure · EX-99.1 to Form 8-K
ASP Isotopes to Hold Capital Markets Day on September 8
Regulation FD disclosure · EX-99.1 to Form 8-K
ASP Isotopes Announces Quantum Leap Energy Research Agreement with Texas A&M Engineering Experiment Station to Advance Uranium Conversion Technology
Regulation FD disclosure · EX-99.1 to Form 8-K
Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations; and
Other events · EX-99.1 to Form 8-K
ASP Isotopes Announces Agreements to Exchange Certain
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
ENDRA Life Sciences Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “ DGCL ”), DOES HEREBY CERTIFY AS FOLLOWS:
Material agreement · Unregistered share sale · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing
Material agreement · Unregistered share sale · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
EX-99.3 to Form 8-K
Material agreement · Unregistered share sale · Regulation FD disclosure · Other events · EX-99.3 to Form 8-K
ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing
Regulation FD disclosure · EX-99.1 to Form 8-K
ASP Isotopes Inc. Announces that a Subsidiary of Renergen Limited Has Entered into its First Take-or-Pay
Regulation FD disclosure · EX-99.1 to Form 8-K
Quantum Leap Energy Enters into Memorandum of Understanding with European Nuclear Technology Company for Advanced Nuclear Fuel Supply Collaboration
Regulation FD disclosure · EX-99.1 to Form 8-K
Quantum Leap Energy Appoints Dr. Peter Fiske to Strategic Advisory Board
Regulation FD disclosure · EX-99.1 to Form 8-K
ASP Isotopes Inc. Provides Business Update
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Regulation FD disclosure · EX-99.2 to Form 8-K
EX-99.3 to Form 8-K
Regulation FD disclosure · EX-99.3 to Form 8-K
ASP Isotopes to Host Business Update Conference Call on April 13, 2026, at 8:00 AM ET
Regulation FD disclosure · EX-99.1 to Form 8-K
ASP Isotopes Announces Strategic Collaboration Between Quantum Leap Energy
Regulation FD disclosure · EX-99.1 to Form 8-K
ASP Isotopes Completes Well Drilling Required for Phase 1
Regulation FD disclosure · EX-99.1 to Form 8-K
ASP Isotopes to Participate in Canaccord Genuity’s 2nd Annual CG Virtual Sustainability Summit
Regulation FD disclosure · EX-99.1 to Form 8-K
Quantum Leap Energy Enters into Memorandum of Understanding with a Large U.S. Energy Company Regarding Evaluation of Support to Advance Domestic Enriched Uranium Fuel Supply Chain
Regulation FD disclosure · EX-99.1 to Form 8-K
Quantum Leap Energy Appoints Nate Salpeter, Ph.D., a Key Opinion Leader in Fluid Dynamics and Energy Technology, as its Chief Technology Officer
Regulation FD disclosure · EX-99.1 to Form 8-K
ASP Isotopes Announces Quantum Leap Energy and Necsa Advance Strategic Collaboration Aimed at Production of HALEU Nuclear Fuel
Regulation FD disclosure · EX-99.1 to Form 8-K
ASP Isotopes Announces Establishment of Quantum Leap Energy
Regulation FD disclosure · EX-99.1 to Form 8-K
ASP Isotopes Announces Quantum Leap Energy to Establish Global Headquarters in Austin, TX
Regulation FD disclosure · EX-99.1 to Form 8-K
ASP Isotopes Inc. Provides Production Update on the Renergen Helium Project
Regulation FD disclosure · EX-99.1 to Form 8-K
ASP Isotopes Closes Acquisition of Renergen
Acquisition or disposition completed · Unregistered share sale · Other events · EX-99.2 to Form 8-K
ASP Isotopes Inc. Announces Receipt of Regulatory Approvals for Acquisition of Renergen Limited
Other events · EX-99.1 to Form 8-K
ASP Isotopes Inc. Announces Paul Mann to Return from Temporary Leave of Absence as Executive Chairman and Chief Executive Officer
Other events · EX-99.1 to Form 8-K
(Incorporated in the Republic of South Africa)
Material agreement · Other events · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
ASP Isotopes to Provide Quarterly Business Update Call on November 21, 2025 at 8:30am EST
Regulation FD disclosure · EX-99.1 to Form 8-K
ASP Isotopes Announces Quantum Leap Energy’s
Regulation FD disclosure · EX-99.1 to Form 8-K